Vaccination in Oncology Patients: Evidence, Clinical Challenges, and Future Directions

Area of Science:

• Oncology
• Immunology
• Infectious Diseases

Background:

• Cancer patients are disproportionately affected by vaccine-preventable infectious diseases.
• Malignancy and cancer treatments cause immune dysfunction and immunosuppression, impairing vaccine responses.
• Vaccine uptake and efficacy are often suboptimal in oncology patients, especially those with hematological malignancies or on intensive therapies.

Purpose of the Study:

• To synthesize current evidence on vaccine immunogenicity, effectiveness, and safety in cancer patients.
• To discuss mechanisms of impaired vaccine responses in this population.
• To address challenges and explore emerging strategies for optimizing vaccination in oncology.

Main Methods:

• Narrative review of existing literature on vaccination in cancer patients.
• Synthesis of data on vaccine immunogenicity, clinical effectiveness, and safety.
• Discussion of immunological factors, clinical challenges, and future perspectives.

Main Results:

• Vaccine responses are frequently attenuated in cancer patients, particularly with hematological malignancies and immunosuppressive therapies.
• Key challenges include timing of vaccination, immune response variability, and vaccine hesitancy.
• Emerging strategies like booster doses, adjuvanted vaccines, and personalized approaches show promise.

Conclusions:

• Vaccination is crucial for supportive care in oncology but requires optimized strategies.
• Addressing immunological barriers and clinical challenges is essential for improving vaccine effectiveness.
• Integrating advanced vaccination approaches into routine oncology care is a critical future direction.